{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:21:41Z","timestamp":1762431701860},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cancer cachexia cannot be easily reversed by standard nutritional support and interventions directed at underlying metabolic derangements may be needed to prevent or reverse cachexia and maintain healthy body composition. The following review will highlight the contribution and potential therapeutic interventions for insulin resistance, alterations in ghrelin signaling, and hypogonadism in cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In addition to decreased caloric intake, chronic inflammation, and altered metabolism of glucose, proteins and lipids, endocrine abnormalities can propagate weight loss or changes in body composition in cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Cancer cachexia, loss of muscle mass with or without the loss of fat mass, is a multifactorial syndrome, which is associated with increased morbidity and mortality. Currently, limited therapeutic options for the treatment of weight loss in cancer patients exist, which lead to clinically meaningful improvements in weight gain and performance status. Treatment directed at underlying insulin resistance, low testosterone, and altered ghrelin sensitivity, in the future, may lead to potential therapeutic options for loss of lean body mass and cancer cachexia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000464","type":"journal-article","created":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:22:45Z","timestamp":1569187365000},"page":"286-291","source":"Crossref","is-referenced-by-count":15,"title":["Endocrinopathies and cancer cachexia"],"prefix":"10.1097","volume":"13","author":[{"given":"Rony","family":"Dev","sequence":"first","affiliation":[{"name":"Symptom Control & Palliative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egidio","family":"Del Fabbro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology, Oncology & Palliative Care, Richmond, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Dalal","sequence":"additional","affiliation":[{"name":"Symptom Control & Palliative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230926","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia; an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R2-20230926","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"R3-20230926","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1477-2574.2010.00178.x","article-title":"Cachexia in pancreatic cancer: new treatment option and measure of success","volume":"12","author":"Fearon","year":"2010","journal-title":"HPB (Oxford)"},{"key":"R4-20230926","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.clnu.2016.09.008","article-title":"Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients","volume":"36","author":"Vigano","year":"2017","journal-title":"Clin Nutr"},{"key":"R5-20230926","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"R6-20230926","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.clnu.2012.05.011","article-title":"The evolutionary benefit of insulin resistance","volume":"31","author":"Soeters","year":"2012","journal-title":"Clin Nutr"},{"key":"R7-20230926","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.1230721","article-title":"Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis","volume":"339","author":"Odegaard","year":"2013","journal-title":"Science"},{"key":"R8-20230926","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11154-014-9306-8","article-title":"Regulation of energy balance by inflammation: common theme in physiology and pathology","volume":"16","author":"Wang","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"R9-20230926","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4158\/EP15647.OR","article-title":"Clinical presentation and long-term outcome of patients with ectopic ACTH syndrome due to bronchial carcinoid tumors: a one-center experience","volume":"21","author":"Tsirona","year":"2015","journal-title":"Endocr Pract"},{"key":"R10-20230926","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.devcel.2015.02.012","article-title":"Systemic organ wasting induced by localized expression of the secreted insulin\/IGF antagonist ImpL2","volume":"33","author":"Kwon","year":"2015","journal-title":"Dev Cell"},{"key":"R11-20230926","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"(12 Pt 1)","key":"R12-20230926","first-page":"5910","article-title":"Glucose metabolism in cachectic patients with colorectal cancer","volume":"44","author":"Holroyde","year":"1984","journal-title":"Cancer Res"},{"key":"R13-20230926","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1200\/JCO.1994.12.6.1126","article-title":"Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed nonsmall-cell lung cancer","volume":"12","author":"Loprinzi","year":"1994","journal-title":"J Clin Oncol"},{"key":"R14-20230926","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R15-20230926","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mehy.2011.04.001","article-title":"The complete control of glucose level utilizing the composition of ketogenic diet with the gluconeogenesis inhibitor, the antidiabetic drug metformin, as a potential anticancer therapy","volume":"77","author":"Oleksysayn","year":"2011","journal-title":"Med Hypotheses"},{"key":"R16-20230926","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1139\/apnm-2013-0369","article-title":"Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment","volume":"39","author":"Chevalier","year":"2014","journal-title":"Appl Physiol Nutr Metab"},{"key":"R17-20230926","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1139\/cjpp-2017-0171","article-title":"Effects of metformin on insulin resistance and metabolic disorder in tumor-bearing rats with advanced cachexia","volume":"96","author":"de Fatima Silva","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"1860.e9","DOI":"10.1016\/j.celrep.2019.07.027","article-title":"p63 and SOX2 dictate glucose reliance and metabolic vulnerabilities in squamous cell carcinomas","volume":"28","author":"Hsieh","year":"2019","journal-title":"Cell Rep"},{"key":"R19-20230926","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-016-0147-7","article-title":"Prediagnosis blood glucose and prognosis in women with breast cancer","volume":"4","author":"Monzavi-Karbassi","year":"2016","journal-title":"Cancer Metab"},{"key":"R20-20230926","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1464-410X.2011.10555.x","article-title":"A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy","volume":"109","author":"Nobes","year":"2012","journal-title":"BJU Int"},{"key":"R21-20230926","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00421-013-2769-6","article-title":"The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production","volume":"114","author":"Krause","year":"2014","journal-title":"Eur J Appl Physiol"},{"key":"R22-20230926","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/japplphysiol.01380.2013","article-title":"AMPK-\u03b12 is involved in exercise training-induced adaptations in insulin-stimulated metabolism in skeletal muscle following high-fat diet","volume":"117","author":"Abbott","year":"2014","journal-title":"J Appl Physiol"},{"key":"R23-20230926","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/diacare.26.3.625","article-title":"Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes","volume":"26","author":"van Loon","year":"2003","journal-title":"Diabetes Care"},{"key":"R24-20230926","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0148607105029003162","article-title":"Quality of life in adult home parenteral nutrition patients","volume":"29","author":"Winkler","year":"2005","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R25-20230926","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Support Care Cancer"},{"key":"R26-20230926","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-017-0873-x","article-title":"When less may be more: calorie restriction and response to cancer therapy","volume":"15","author":"O\u2019Flanagan","year":"2017","journal-title":"BMC Med"},{"key":"R27-20230926","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"R28-20230926","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/400_2007_049","article-title":"Structure and function of ghrelin","volume":"46","author":"Kojima","year":"2008","journal-title":"Results and problems in cell differentiation"},{"key":"R29-20230926","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpeds.2003.10.036","article-title":"Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation","volume":"144","author":"Soriano-Guillen","year":"2004","journal-title":"J Pediatr"},{"key":"R31-20230926","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"J Clin Invest"},{"key":"R32-20230926","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","article-title":"Therapeutic action of ghrelin in a mouse model of colitis","volume":"130","author":"Gonzalez-Rey","year":"2006","journal-title":"Gastroenterology"},{"key":"R33-20230926","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","article-title":"Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways","volume":"143","author":"Waseem","year":"2008","journal-title":"Surgery"},{"key":"R34-20230926","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(03)00789-4","article-title":"Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats","volume":"349","author":"Yasuda","year":"2003","journal-title":"Neurosci Lett"},{"key":"R35-20230926","first-page":"95","article-title":"Central and peripheral mechanisms by which ghrelin regulates gut motility","volume":"54","author":"Peeters","year":"2003","journal-title":"J Physiol Pharmacol"},{"key":"R36-20230926","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/17460440903300842","article-title":"Animal models of anorexia and cachexia","volume":"4","author":"DeBoer","year":"2009","journal-title":"Expert Opin Drug Discov"},{"key":"R37-20230926","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"R38-20230926","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-291X(02)03028-0","article-title":"Anticachectic effect of ghrelin in nude mice bearing human melanoma cells","volume":"301","author":"Hanada","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-20230926","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-20230926","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomized, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer"},{"key":"R41-20230926","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.24917","article-title":"Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study","volume":"116","author":"Lundholm","year":"2010","journal-title":"Cancer"},{"key":"R42-20230926","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with nonsmall cell lung cancer and cachexia: results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"key":"R43-20230926","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONA-7643) for the treatment of patients with nonsmall cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONA-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"R44-20230926","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with nonsmall-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomized, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"R45-20230926","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced nonsmall-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"R46-20230926","doi-asserted-by":"crossref","first-page":"1534734518823269","DOI":"10.1177\/1534735418823269","article-title":"Augmentation of cancer cachexia components with targeted acupuncture in patients with gastrointestinal cancers: a randomized controlled pilot study","volume":"18","author":"Grundmann","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"R47-20230926","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncpendmet0120","article-title":"Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging","volume":"2","author":"Bhasin","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R48-20230926","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-8587(18)30171-2","article-title":"Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials","volume":"6","author":"Bhasin","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R49-20230926","first-page":"1167","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"69","author":"Ponikowski","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R50-20230926","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"von Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"R51-20230926","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCHEARTFAILURE.111.965632","article-title":"Testosterone supplementation in heart failure: a meta-analysis","volume":"5","author":"Toma","year":"2012","journal-title":"Circ Heart Fail"},{"key":"R52-20230926","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-20230926","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2009.09.021","article-title":"Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report","volume":"39","author":"Del Fabbro","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"R54-20230926","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.283.6.763","article-title":"Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels","volume":"283","author":"Bhasin","year":"2000","journal-title":"JAMA"},{"key":"R55-20230926","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00520-013-1832-5","article-title":"Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial","volume":"21","author":"Del Fabbro","year":"2013","journal-title":"Support Care Cancer"},{"key":"R56-20230926","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jcsm.12295","article-title":"A randomised trial of adjunct testosterone for cancer-related muscle loss in men and women","volume":"9","author":"Wright","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R57-20230926","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jgo.2017.07.004","article-title":"Short physical performance battery, usual gait speed, grip strength and vulnerable elders survey each predict functional decline among older women with breast cancer","volume":"8","author":"Owusu","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"R58-20230926","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/gerona\/glq167","article-title":"Predictive value of the Short Physical Performance Battery following hospitalization in older patients","volume":"66","author":"Volpato","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R59-20230926","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R60-20230926","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16497.1","article-title":"The effects of testosterone replacement therapy on the prostate: a clinical perspective","volume":"8","author":"Miah","year":"2019","journal-title":"F1000Res"},{"key":"R61-20230926","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomized controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"R62-20230926","first-page":"199","article-title":"Clinical results in cachexia therapeutics","volume":"19","author":"Crawford","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:35:49Z","timestamp":1695713749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000464","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}